Our infectious disease specialists provide consult services to patients. Clinical services are provided at both inpatient and outpatient settings.
IDS faculty physicians pursue a team approach to providing exceptional patient care, working closely with hematologists and oncologists on individual treatment plans for patients. Our researcher physicians also oversee critical quality-improvement initiatives related to infectious diseases, including the development of standard practice guidelines and other clinical care guidelines in infection control and antibiotics management.
- Partnering with hematologists and oncologists on treatment plans
- Overseeing quality exercises related to infectious diseases
- Developing standard practices and guidelines in infection prevention and control
- Conducting pre-transplant evaluations
- Managing patient follow-up visits, including antibiotics management
- Creating long-term follow-up plans
Patient appointments are limited to current patients and require a referral from your Fred Hutch primary provider.
Our faculty work at the interface of patient care and scientific discovery.
In partnership with the patient and a multidisciplinary team, our clinicians strive to provide the highest quality care. As leaders of clinical research and trials, IDS faculty advance scientific knowledge to improve treatment and prevention of the infectious diseases that afflict our patients.
Pooja Bhattacharyya, PA-C
With a background in hematopoetic cell transplant, Bhattacharyya is applying that knowledge to working with patients with infectious disease issues while continuing to provide thorough and compassionate care.
Michael J. Boeckh, MD, PhD
Dr. Boeckh studies infections in the immunocompromised host, especially diagnosis, prevention and treatment of CMV, VZV, BK virus, adenovirus and respiratory virus infections.
Jim Boonyaratanakornkit, MD, PhD
Dr. Boonyaratanakornkit studies the epidemiology and immunology of respiratory viral infections. His research is focused on developing diagnostics, vaccines, and therapeutics against respiratory viruses.
Larry Corey, MD
Dr. Corey's focus is on treating and diagnosing infectious diseases of the immunocompromised patient.
Emily S. Ford, MD
Dr. Ford is interested in the care and treatment of infections in immunocompromised patients.
David N. Fredricks, MD
Dr. Fredricks' focus is on the use of molecular methods for the diagnosis of bacterial and fungal infections.
Adam P. Geballe, MD
Dr. Geballe's focus is on the interactions between the cellular antiviral protein kinase R (PKR) and viral PKR antagonists expressed by human cytomegalovirus, and vaccinia virus.
Joshua A. Hill, MD
Dr. Hill specializes in treating viral infections in immunocompromised cancer patients.
Regina Lengermann, PA-C
Lengermann brings her experience in blood and marrow tranplantation and immunotherapy to provide care for her patients.
Catherine Liu, MD
Dr. Liu focuses on improving patient outcomes through antimicrobial stewardship and outpatient parenteral antimicrobial therapy programs, by promoting appropriate use of antibiotics and optimizing transitions of care.
Denise McCulloch, MD, MPH
Dr. McCulloch is interested in treating and preventing infections in people who have cancer and whose immune systems are suppressed.
Steven A. Pergam, MD, MPH
Dr. Pergam's focus is in the area of CMV and gastrointestinal systems in transplant and cancer patients.
Warren T. Phipps, MD, MPH
Dr. Phipps is interested in human herpesvirus-8 (HHV-8) virology and pathogenesis of Karposi sarcoma (KS), the most common HIV-associated malignancy worldwide.
Joshua T. Schiffer, MD, MSc
Dr. Schiffer is interested in describing the quantitative and dynamic features of human pathogens and immune responses.
Lisa M. So, PA-C
So enjoys working and providing care for people of all ages and backgrounds. She brings her molecular biology education as well as her bone marrow transplant service experience to provide care for her patients.
Asa Tapley, MD, MSc
Dr. Tapley specializes in the prevention, diagnosis, and treatment of infectious diseases, including HIV and tuberculosis.
Ralph Tayyar, MD
Dr. Tayyar is interested in infections in immunocompromised patients, especially in the areas of antimicrobial stewardship, medical education and fungal infections.
Anna Wald, MD, MPH
Dr. Wald is interested in epidemiology, natural history, therapy and prevention of HSV and other herpesvirus infections, including the interactions between HSV and HIV.
Rhonda Warren, PA-C
Warren brings her experience in infections in immunocompromised patients to help patients with complex infections during cancer treatment.
Leah H. Yoke, MCHS, PA-C
As a physician assistant, Yoke’s goal is to create a space where patients and their loved ones feel comfortable enough to honestly discuss their goals of care from an Infectious Disease standpoint. She strives to provide evidence-based, compassionate, unbiased care for every patient she sees.
Danniel Zamora, MD
Dr. Zamora is interested in a patient-centered approach to treating infectious diseases in immunocompromised patients.
The Debra Mattson Award was established in honor of Debra Mattson's 30-year career in caring for thousands of patients and her role in the Infectious Disease Consult Service. As a physician assistant, Mattson provided care with kindness and respect while having a thorough knowledge of the patient’s infectious disease issues. The award looks for the best paper or abstract that addresses improving the diagnosis, prevention and treatment of infections in immunocompromised cancer patients.
The award is open to current students, nurses, APPs, fellows or junior faculty with an appointment at the University of Washington, Seattle Children's Hospital or Fred Hutch Cancer Center.